- Home
- ADAP vs LMFA Comparison
ADAP vs LMFA Comparison
Compare ADAP & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- LMFA
- Stock Information
- Founded
- ADAP 2008
- LMFA 2008
- Country
- ADAP United Kingdom
- LMFA United States
- Employees
- ADAP N/A
- LMFA N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- LMFA Finance: Consumer Services
- Sector
- ADAP Health Care
- LMFA Finance
- Exchange
- ADAP Nasdaq
- LMFA Nasdaq
- Market Cap
- ADAP 21.3M
- LMFA 18.9M
- IPO Year
- ADAP 2015
- LMFA 2015
- Fundamental
- Price
- ADAP $0.08
- LMFA $1.03
- Analyst Decision
- ADAP Hold
- LMFA Strong Buy
- Analyst Count
- ADAP 6
- LMFA 1
- Target Price
- ADAP $1.02
- LMFA $5.00
- AVG Volume (30 Days)
- ADAP 106.3M
- LMFA 596.9K
- Earning Date
- ADAP 11-12-2025
- LMFA 11-12-2025
- Dividend Yield
- ADAP N/A
- LMFA N/A
- EPS Growth
- ADAP N/A
- LMFA N/A
- EPS
- ADAP N/A
- LMFA N/A
- Revenue
- ADAP $65,084,999.00
- LMFA $6,755,925.00
- Revenue This Year
- ADAP N/A
- LMFA N/A
- Revenue Next Year
- ADAP $24.70
- LMFA $15.59
- P/E Ratio
- ADAP N/A
- LMFA N/A
- Revenue Growth
- ADAP N/A
- LMFA N/A
- 52 Week Low
- ADAP $0.04
- LMFA $0.89
- 52 Week High
- ADAP $0.86
- LMFA $5.14
- Technical
- Relative Strength Index (RSI)
- ADAP 41.40
- LMFA 39.20
- Support Level
- ADAP $0.04
- LMFA $0.89
- Resistance Level
- ADAP $0.24
- LMFA $1.14
- Average True Range (ATR)
- ADAP 0.04
- LMFA 0.12
- MACD
- ADAP -0.01
- LMFA -0.01
- Stochastic Oscillator
- ADAP 15.65
- LMFA 27.66
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.